Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
...
Moleac is pleased to announce the release of the ATHENE study results, published in the Journal of the American Medical Director Association (JAMDA)1....
CHIMES-E (Extension) aimed at evaluating the effects of an initial 3-month treatment with NeuroAiD™ on long-term outcomes for up to 2 years after an...
Moleac se complace en anunciar la divulgación de los resultados del estudio CHIMES-E publicados en línea en la revista Cerebrovascular Diseases1. Se...
Moleac, a revenue-generating Biopharma company focused on stroke recovery, announced today the appointment of Mr Elmar Schnee as non-executive...
- La société savante CHIMES (cf. dernière page) a mené le premier grand essai clinique évaluant un médicament d'origine naturelle dans le traitement...
NeuroAiD, a stroke treatment based on Traditional Chinese Medicine, increases the odds of achieving a better functional outcome, according to...
Authors of a medical paper published in this month's Cerebrovascular Diseases journal found that NeuroAiD™, developed by Moleac, significantly...
Biopharmaceutical Company Moleac has announced the launch in France and Belgium of NurAiD II. NurAiD II is a natural health supplement engineered to...
Moleac, société biopharmaceutique, annonce le lancement de son supplément alimentaire NurAiD II en France. Ce produit, principalement destiné à aider ...
In June 2011, "Neuropharmacology" published a paper establishing NeuroAiD's reparative effects on global cerebral ischemia. Global cerebral ischemia...
Moleac Pte Ltd has been granted the Emerging Company of the Year 2010 Award by BioSpectrum, the leading integrated media platform for the Life...
The January issue of "Neuropharmacology", publishes the article entitled "Neuroprotective and Neuroproliferative Activities of NeuroAiD", reporting...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.